← Leaderboards
Colleen M McClean
Duke University
$121,384
Attributed
$121,384
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50K · FY2017–19$100K$75K$50K$25K$0
'17
'18
'19
Funding mix
By agency
NIH$121,384 · 1
By mechanism
F30$121,384 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- David M. Tobin$14,570,630
- Sunhee Lee$3,274,709
- David Matus$3,062,861
- Edward A Miao$16,675,058
- Joern Coers$11,586,711
Others in their field
Other Emerging Leaders on “Apolipoprotein A-Ii”
- Robert Sidney Rosenson · Icahn School Of Medicine At Mount Sinai$2,516,907
- Anna Podolanczuk · Columbia University Health Sciences$686,448
- Linda Zhang · Vanderbilt University$183,846
- Miles Henry Black · Ut Southwestern Medical Center$102,054
Research focus
Apolipoprotein A-IiApolipoproteinsAreaBurden Of IllnessCellsCharacteristicsCholesterolComplexDefined ContributionDown-RegulationExperimental StudyGeneticGenus MycobacteriumGranulomaGranulomatousGrowthImageryImmuneImmune ResponseImmunologicsImmunoregulationInfectionInvestigationAnimals
Grant awards (3)
Role of Cholesterol Efflux Blockade in Mycobacterial Infection In Vivo$50,016
F30 · FY2019 · AI · contact PI
Role of Cholesterol Efflux Blockade in Mycobacterial Infection In Vivo$36,064
F30 · FY2018 · AI · contact PI
Role of Cholesterol Efflux Blockade in Mycobacterial Infection In Vivo$35,304
F30 · FY2017 · AI · contact PI